HealthQuill The Global Fund
Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at no profit to benefit two million people in low-income nations.
Drugs Health Pharma

Gilead, Global Fund to supply HIV prevention drug to two million people

HQ Team July 10, 2025: Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at.

Read More